Immutep Limited Stock Market Value

PRRUF Stock  USD 0.20  0.00  0.00%   
Immutep's market value is the price at which a share of Immutep trades on a public exchange. It measures the collective expectations of Immutep Limited investors about its performance. Immutep is trading at 0.2 as of the 11th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.2.
With this module, you can estimate the performance of a buy and hold strategy of Immutep Limited and determine expected loss or profit from investing in Immutep over a given investment horizon. Check out Immutep Correlation, Immutep Volatility and Immutep Alpha and Beta module to complement your research on Immutep.
Symbol

Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immutep 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immutep's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immutep.
0.00
11/11/2024
No Change 0.00  0.0 
In 31 days
12/11/2024
0.00
If you would invest  0.00  in Immutep on November 11, 2024 and sell it all today you would earn a total of 0.00 from holding Immutep Limited or generate 0.0% return on investment in Immutep over 30 days. Immutep is related to or competes with Zura Bio, Enveric Biosciences, Immix Biopharma, Elevation Oncology, Design Therapeutics, Alx Oncology, and Aadi Bioscience. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products More

Immutep Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immutep's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immutep Limited upside and downside potential and time the market with a certain degree of confidence.

Immutep Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immutep's standard deviation. In reality, there are many statistical measures that can use Immutep historical prices to predict the future Immutep's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immutep's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.203.30
Details
Intrinsic
Valuation
LowRealHigh
0.010.173.27
Details
Naive
Forecast
LowNextHigh
00.193.29
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.180.210.25
Details

Immutep Limited Backtested Returns

Immutep Limited holds Efficiency (Sharpe) Ratio of -0.0545, which attests that the entity had a -0.0545% return per unit of risk over the last 3 months. Immutep Limited exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immutep's Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.36), and Standard Deviation of 3.02 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.47, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immutep's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immutep is expected to be smaller as well. At this point, Immutep Limited has a negative expected return of -0.17%. Please make sure to check out Immutep's information ratio and rate of daily change , to decide if Immutep Limited performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Immutep Limited has no correlation between past and present. Overlapping area represents the amount of predictability between Immutep time series from 11th of November 2024 to 26th of November 2024 and 26th of November 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immutep Limited price movement. The serial correlation of 0.0 indicates that just 0.0% of current Immutep price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Immutep Limited lagged returns against current returns

Autocorrelation, which is Immutep pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immutep's pink sheet expected returns. We can calculate the autocorrelation of Immutep returns to help us make a trade decision. For example, suppose you find that Immutep has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Immutep regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immutep pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immutep pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immutep pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Immutep Lagged Returns

When evaluating Immutep's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immutep pink sheet have on its future price. Immutep autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immutep autocorrelation shows the relationship between Immutep pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Immutep Limited.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Immutep Pink Sheet

Immutep financial ratios help investors to determine whether Immutep Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immutep with respect to the benefits of owning Immutep security.